Endometrin — Class II drug recall D-0879-2023
Terminated recall by Ferring Pharmaceuticals Inc, reported 2023-07-05, distributed nationwide. cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
| Recall number | D-0879-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Recalling firm | Ferring Pharmaceuticals Inc, Parsippany, NJ, United States |
| Recall initiated | 2023-06-12 |
| Classified | 2023-06-26 |
| Reported by FDA | 2023-07-05 |
| Terminated | 2024-08-05 |
| Distributed | Nationwide (US) |
| Reason classes | microbial contamination, sterility, cgmp |
| NDC | 55566-6500-03 |
| Expiration dates | 2025-12 |
Product
Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03
Reason for recall
cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0879-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.